NVS
HOLD / NEUTRALMeanRevComposite
43.70
Technical
57.20
Fundamental
39.20
Rank
—
Price
153.87
Hurst
0.37
As of
Jul 22, 2026
Daily
Novartis AG
HealthcareDrug Manufacturers - GeneralNovartis is a global pharmaceutical company based in Switzerland that develops and manufactures medicines across multiple therapeutic areas including cardiovascular, oncology, immunology, and rare diseases. The company's product portfolio includes treatments for conditions such as heart failure, cancer, psoriasis, leukemia, asthma, and spinal muscular atrophy, among others. Novartis also maintains partnerships with other organizations to advance its drug development and research capabilities.
Market cap
$303.7B
P/E (trailing)
30.69
P/E (forward)
16.18
PEG ratio
3.84
Dividend yield
295.00%
Beta
0.47
52w range
122.86 – 170.46
Return on equity
+24.33%
Profit margin
+17.49%
Revenue growth
+4.70%
Earnings growth
-68.80%
Price history
1Y: 160.79 (+33.8%) · range 120.13–163.64
Cycle position
69/ 100 cycle scoreAPPROACHING EXIT
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 14 · NOT READY · exit proximity 0
Conviction
28/ 100 · maturity 43%
VScore.2215
Buildup.2647
EMA entry setup.3214
Fundamentals.1939
Volume profile
POC
154.31
Price vs POC
+4.2%
Overhead supply
6%
Runway
open sky
Value area 145.79–162.28 · 6% of 120d volume overhead · clean runway
Contributing sources
| Source | Score | Last seen |
|---|---|---|
| earnings-surprise | 0.560 | Oct 30, 2026 |
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +4.72% | +4.72% | mature |
| 40d | -7.94% | +6.54% | mature |